News Summary

Mindstate Design Labs, a startup founded in 2021 and backed by prominent investors including Y Combinator and founders of OpenAI, Neuralink, Instacart, Coinbase, and Twitch, is pioneering the development of psychedelics without the traditional hallucinogenic effects. The company employs AI to design psychedelic-like drugs that induce specific mental states. Their first compound, MSD-001, demonstrated promising results in a Phase I trial, safely producing psychoactive effects without hallucinations in 47 participants. This innovation could revolutionize treatments for severe mental health conditions by utilizing the brain’s serotonin system to promote neuroplasticity, potentially offering therapeutic benefits without the need for a ‘trip’.